In an effort to expand its gastroenterology portfolio, Allergan plans to acquire Tobira Therapeutics for up to $1.69 billion.
The FDA approved STELARA, a Crohn’s disease treatment developed by Janssen Biotech.
Boston Scientific is the leading competitor in the GI/endoscopic device market, followed by Olympus.
The Israeli medical device company MOTUS GI received FDA clearance for its Pure-Vu System.
Cantel Medical acquired endoscope reprocessing business assets from Vantage Endoscopy.
Surgical Endoscopy published the results of a three-year controlled trial concerning long-term chronic gastroesophageal reflux disease control after a transoral incisionless fundoplication procedure with EsophyX, a device developed by EndoGastric Solutions.
Takeda Pharmaceutical was named one of Working Mother magazine’s “Working Mother 100 Best Companies.”
More articles on gastroenterology and endoscopy:
GI societies objects to American Board of Internal Medicine’s certification proposals: 4 notes
FDA clears Pure-Vu System for intra-procedural colon cleaning: 3 notes
Takeda named in Working Mother’s top companies: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
